UroStream

Editor’s Note: With sails raised and talents converging, the 15th Shanghai Urologic Oncology Academic Conference, hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of…

Editor’s Note: The 15th Shanghai Urological Oncology Academic Conference, hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urological Oncology Committee of the Shanghai Anti-Cancer Association and Fudan…

15th Shanghai Urologic Oncology Academic Conference Editor’s Note: Hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of the Shanghai Anti-Cancer Association and Fudan University…

15th Shanghai Urologic Oncology Academic Conference Editor’s Note: Hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of the Shanghai Anti-Cancer Association and Fudan University…

“Fewer Cores Without Losing Accuracy” — A New Strategy of MRI-Targeted Biopsy Plus Ipsilateral Systematic Biopsy of the Index Lesion in Prostate Cancer Editor’s Note: Prostate cancer is one of…

Editor’s Note: Advanced urothelial carcinoma is a highly aggressive malignancy associated with poor prognosis, posing a serious threat to patient survival and quality of life. In recent years, continuous breakthroughs…

Editor’s Note The incidence of upper tract urothelial carcinoma (UTUC) in China is significantly higher than in Western countries. Although radical nephroureterectomy remains the gold standard for treatment, a substantial…

Editor’s Note: From November 10–16, 2025, the 9th West China Urologic Oncology Tianfu Academic Conference and the 11th Academic Annual Meeting on Urologic and Male Genitourinary Tumors of the Sichuan…

Editor’s note: Upper tract urothelial carcinoma (UTUC) accounts for about 17.9% of all urothelial carcinomas (UC) in China. For high-risk UTUC, radical nephroureterectomy (RNU) is the standard surgical procedure, but…

Editor’s note: The incidence of genitourinary cancers in China has continued to rise, with prostate, bladder, and kidney cancers ranking among the most common malignancies. Among them, eosinophilic renal tumors…